Menopause before 40: premature ovarian insufficiency (POI)
When ovarian activity changes earlier than expected, the hormone conversation changes too. Diagnosis, replacement, fertility and how you're feeling all deserve time.
Guide, not prescription. Your doctor or specialist checks what fits your history.
What POI means
POI means loss of ovarian activity before 40. It can cause irregular or absent periods and low estrogen. Ovarian activity can return intermittently, so it isn't always a complete, permanent stop.
Early menopause means menopause from 40 to 44. Menopause at the usual age happens later. Losing ovarian hormones before 40 is a different health situation from first considering MHT at 55.
The 2024 guideline uses at least four months of irregular or absent cycles and a raised FSH blood result for diagnosis. Pregnancy and other causes need checking. Repeat blood work can help if the diagnosis is uncertain; hormone medicines can affect interpretation.
With POI, the body can be missing hormones it would ordinarily still be making. Hormone therapy isn't only a response to hot flashes: bone health and the effects of early hormone loss matter too.
The international guideline generally recommends hormone therapy until the usual age of natural menopause, around 51, unless there's a reason it's unsuitable. This applies even without symptoms. At that point, review the benefits and risks together rather than automatically stopping.
A uterus that's still present usually needs a progestogen alongside systemic estrogen to protect its lining. Hormone-sensitive cancer and other health histories can change the plan. Gender-affirming hormones need an individual review rather than an automatic extra prescription.
POI treatment aims for adequate hormone replacement, not only the lowest dose that quiets symptoms. That can mean a different dose conversation from menopause at the usual age. There isn't one right dose or route for everyone.
Ask what the treatment is replacing and how bone health fits the plan.
Discuss the route, any uterine protection, contraception and medicines you already use.
Agree on follow-up, side effects, bleeding changes and when to seek advice.
Guide, not prescription. Don't change or combine hormones on your own.
Confirm the diagnosis. Discuss cycle changes, symptoms, pregnancy testing and how any hormone medicines affect blood work.
Ask about a baseline bone-density scan. DXA, sometimes written DEXA, is recommended at diagnosis.
Discuss the cause. For POI that wasn't caused by treatment or surgery, the guideline recommends chromosome analysis and FMR1 fragile X premutation testing, with counselling.
Check thyroid and adrenal questions. TSH checks thyroid function. When the cause is unknown, ask about 21-hydroxylase antibodies for adrenal autoimmunity. Routine thyroid-peroxidase antibody screening isn't recommended.
Discuss uterine protection. If you have a uterus and use systemic estrogen, ask about progestogen options, including a levonorgestrel IUD. Mirena and menopause explains this role and the replacement schedule.
Make space for fertility and contraception. With non-surgical POI, intermittent ovarian activity and natural conception remain possible, but aren't predictable. Hormone replacement isn't contraception. If you don't want to become pregnant, discuss contraception that fits you, including whether a levonorgestrel IUD could cover both contraception and uterine protection. Read Mirena and menopause.
Name the emotional weight. Grief, uncertainty, relief or a mix can be part of this. You don't have to want children for the diagnosis to feel heavy. Ask for counselling or peer support if you'd like it.
POI can affect people with ovaries, including trans men and nonbinary people. The guideline acknowledges gender-diverse people, while noting that much of the research uses women-only populations and language.
Testosterone can stop periods, so bleeding changes alone can't diagnose or rule out POI. Don't rely on testosterone as proven protection against POI. If symptoms or concerns arise, ask about blood work and an assessment that takes your hormone use into account. Evidence specific to POI during testosterone therapy is limited.
Testosterone isn't reliable contraception. If you don't want to become pregnant and pregnancy is possible for you, ask about options that fit your body and preferences.
If your periods stopped before 40 and hormones haven't come up: ask whether POI needs investigating and what replacement might mean for you.
If surgery removed both functioning ovaries:read surgical menopause . The timing and cause are different, even where follow-up overlaps.
If cancer treatment changed ovarian activity:read menopause after cancer . Recovery of ovarian function and treatment choices depend on your cancer and treatment history.
Grade A identifies guideline-supported care, not certainty about every outcome or personal eligibility. Some POI recommendations rely on limited evidence or expert agreement.
Grade A anchor: diagnose POI carefully and discuss hormone replacement, bone health, fertility and support.
Clinical guidelineESHRE / ASRM / IMS / CRE-WHiRL, International POI guideline · 2024
Panay et al.; evidence-based guideline, not a single participant cohort
Developed and funded by ESHRE, ASRM, CRE-WHiRL and IMS. Guideline members weren't paid; several disclosed pharmaceutical research, consultancy or honoraria relationships. The full disclosure is in the source. Evidence strength differs between recommendations.
Grade C context: testosterone-associated absence of periods isn't reliable contraception.
Narrative reviewFertility counselling guide for transgender and gender diverse people · 2023
An expert counselling guide, not a POI trial. It doesn't establish that testosterone prevents or causes POI. No single participant count; the authors report no associated funding and no conflicts of interest.
